Skip to main content

Adtalem Global Education Inc

For the period ended Sep 30, 2024. Filed Oct 29, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Oct 29, 2024

CVSA$116.50+2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

(in thousands)

​​​​​​​
​ · ​ · Three Months Ended
​ · ​ · September 30,
​ · ​ · 2024 · ​ · 2023
Operating activities:​​​​​​
Net income​$46,165​$10,646
Loss from discontinued operations​80​1,313
Income from continuing operations​​46,245​​11,959
Adjustments to reconcile net income to net cash provided by operating activities:​​​​
Stock-based compensation​9,451​7,455
Amortization and impairments to operating lease assets​​6,948​​8,765
Depreciation​9,803​9,338
Amortization of acquired intangible assets​2,805​10,677
Amortization of debt discount and issuance costs​​1,113​​1,155
Provision for bad debts​​13,720​​10,226
Deferred income taxes​16,456​2,165
Loss on disposals of property and equipment​107​38
(Gain) loss on investments​​(613)​​447
Changes in assets and liabilities:​​​​
Accounts and financing receivables​(56,803)​(54,867)
Prepaid expenses and other current assets​(7,389)​(5,532)
Cloud computing implementation assets​(7,888)​(4,224)
Accounts payable​(8,508)​(2,818)
Accrued payroll and benefits​​(21,501)​​(8,882)
Accrued liabilities​(8,467)​13,770
Deferred revenue​106,156​98,658
Operating lease liabilities​​(7,232)​​(10,053)
Other assets and liabilities​(4,836)​(2,163)
Net cash provided by operating activities-continuing operations​89,567​86,114
Net cash (used in) provided by operating activities-discontinued operations​(251)​8,959
Net cash provided by operating activities​89,316​95,073
Investing activities:​​​​​
Capital expenditures​(10,414)​(10,434)
Proceeds from sales of marketable securities​2,187​400
Purchases of marketable securities​(1,308)​(300)
Net cash used in investing activities​(9,535)​(10,334)
Financing activities:​​​​​
Proceeds from exercise of stock options​9,498​550
Employee taxes paid on withholding shares​(10,717)​(5,651)
Proceeds from stock issued under Colleague Stock Purchase Plan​298​190
Repurchases of common stock for treasury​(33,190)​(90,477)
Proceeds from issuance of long-term debt​9,873​—
Repayments of long-term debt​(9,873)​—
Net cash used in financing activities​(34,111)​(95,388)
Net increase (decrease) in cash, cash equivalents and restricted cash​45,670​(10,649)
Cash, cash equivalents and restricted cash at beginning of period​221,202​275,075
Cash, cash equivalents and restricted cash at end of period​$266,872​$264,426
Non-cash investing and financing activities:​​​​​​
Accrued capital expenditures​$4,193​$6,087
Accrued liability for repurchases of common stock​$800​$3,600
Accrued excise tax on share repurchases​$3,259​$1,928
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.